11. FINANCIAL INSTRUMENTS	12 Months Ended
Jun. 30, 2015
Investments, All Other Investments [Abstract]
11. FINANCIAL INSTRUMENTS	The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a multinomial lattice model as of June 30, 2015, and 2014. The fair values of the derivative instruments are measured each quarter, which resulted in a gain (loss) of $(1,545,181) and $0, and derivative expense of $524,518 and $0 during the fiscal years ended June 30, 2015 and 2014, respectively. As of June 30, 2015 and 2014, the fair market value of the derivatives aggregated $12,814,941 and $0, respectively, using the following assumptions: estimated 10-0.10 year term, estimated volatility of 141.46 -70.62%, and a discount rate of 2.35-0.00%.

11. FINANCIAL INSTRUMENTS

12 Months Ended

Jun. 30, 2015

Investments, All Other Investments [Abstract]

The Company has financial instruments that are considered derivatives or contain embedded features subject to derivative accounting. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in the Company’s balance sheet. The Company measures these instruments at their estimated fair value and recognizes changes in their estimated fair value in results of operations during the period of change. The Company has estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a multinomial lattice model as of June 30, 2015, and 2014. The fair values of the derivative instruments are measured each quarter, which resulted in a gain (loss) of $(1,545,181) and $0, and derivative expense of $524,518 and $0 during the fiscal years ended June 30, 2015 and 2014, respectively. As of June 30, 2015 and 2014, the fair market value of the derivatives aggregated $12,814,941 and $0, respectively, using the following assumptions: estimated 10-0.10 year term, estimated volatility of 141.46 -70.62%, and a discount rate of 2.35-0.00%.